Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL VASCULAR STENTS MARKET, BY TYPE
6.1. Overview
6.2. Coronary Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.1. Carotid Artery Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.2. Renal Artery Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.3. Femoral Artery Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.4. Iliac Artery Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.5. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Peripheral Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Evar Stent Grafts
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4.1. Abdominal Aortic Aneurysm Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4.2. Thoracic Aortic Aneurysm Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL VASCULAR STENTS MARKET, BY MATERIAL
7.1. Overview
7.2. Metallic Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.1. Platinum Chromium
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.2. Cobalt-Chromium
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.3. Nickel Titanium
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.2.4. Stainless Steel
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. Ceramics Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Polymers Stents
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL VASCULAR STENTS MARKET, BY END USER
8.1. Overview
8.2. Hospitals
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Cardiac Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4. Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9. GLOBAL VASCULAR STENTS MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Vascular Stents Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Vascular Stents Market
10.7. Key developments and Growth Strategies
10.7.1. Product Launch/Service Deployment
10.7.2. Mergers and Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix & Market Ratio
10.8.1. Sales & Operating Income 2020
10.8.2. Major Players R&D Expenditure 2020
10.9. Major Players Capital Market Ratio
11. COMPANY PROFILES
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Overview
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. B. Braun Melsungen Ag
11.2.1. Company Overview
11.2.2. Product Overview
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Medtronic Plc
11.3.1. Company Overview
11.3.2. Product Overview
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Boston Scientific Corporation
11.4.1. Company Overview
11.4.2. Product Overview
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Terumo Corporation
11.5.1. Company Overview
11.5.2. Product Overview
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Biotronik Se & Co. Kg
11.6.1. Company Overview
11.6.2. Product Overview
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Microport Scientifc Corporation
11.7.1. Company Overview
11.7.2. Product Overview
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Cook Medical
11.8.1. Company Overview
11.8.2. Product Overview
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Vascular Concepts
11.9.1. Company Overview
11.9.2. Product Overview
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Stentys S.A.
11.10.1. Company Overview
11.10.2. Product Overview
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. C. R. Bard
11.12. Meril Life Sciences
11.13. Cordis Corporation
11.14. W. L. Gore & Associates
11.15. Others
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL VASCULAR STENTS MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL VASCULAR STENTS MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL VASCULAR STENTS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
TABLE 10 US: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 11 US: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 12 US: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
TABLE 13 CANADA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 14 CANADA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 15 CANADA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
TABLE 16 LATIN AMERICA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 17 LATIN AMERICA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 18 LATIN AMERICA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
TABLE 19 EUROPE: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 20 EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 21 EUROPE: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY MATERIAL, 2020-2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET, BY END USE, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE OF THE GLOBAL VASCULAR STENTS MARKET
FIGURE 3 MARKET DYNAMICS OF THE GLOBAL VASCULAR STENTS MARKET
FIGURE 4 GLOBAL VASCULAR STENTS MARKET SHARE, BY TYPE, 2020 (%)
FIGURE 5 GLOBAL VASCULAR STENTS MARKET SHARE, BY MATERIAL, 2020 (%)
FIGURE 6 GLOBAL VASCULAR STENTS MARKET SHARE, BY END USE, 2020 (%)
FIGURE 7 GLOBAL VASCULAR STENTS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 8 AMERICAS: VASCULAR STENTS MARKET SHARE BY REGION, 2020 (%)
FIGURE 9 NORTH AMERICA: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 10 EUROPE: VASCULAR STENTS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 11 WESTERN EUROPE: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 12 ASIA-PACIFIC: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 13 MIDDLE EAST & AFRICA: VASCULAR STENTS MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 GLOBAL VASCULAR STENTS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 15 ABBOTT LABORATORIES.: KEY FINANCIALS
FIGURE 16 ABBOTT LABORATORIES: SEGMENTAL REVENUE
FIGURE 17 ABBOTT LABORATORIES: REGIONAL REVENUE
FIGURE 18 B. BRAUN MELSUNGEN AG: KEY FINANCIALS
FIGURE 19 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE
FIGURE 20 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE
FIGURE 21 MEDTRONIC PLC: KEY FINANCIALS
FIGURE 22 MEDTRONIC PLC: SEGMENTAL REVENUE
FIGURE 23 MEDTRONIC PLC: REGIONAL REVENUE
FIGURE 24 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS
FIGURE 25 BOSTON SCIENTIFIC CORPORATION: SEGMENTAL REVENUE
FIGURE 26 BOSTON SCIENTIFIC CORPORATION: REGIONAL REVENUE
FIGURE 27 TERUMO CORPORATION: KEY FINANCIALS
FIGURE 28 TERUMO CORPORATION: SEGMENTAL REVENUE
FIGURE 29 TERUMO CORPORATION: REGIONAL REVENUE
FIGURE 30 BIOTRONIK SE & CO. KG: KEY FINANCIALS
FIGURE 31 BIOTRONIK SE & CO. KG: SEGMENTAL REVENUE
FIGURE 32 BIOTRONIK SE & CO. KG: REGIONAL REVENUE
FIGURE 33 MICROPORT SCIENTIFC CORPORATION: KEY FINANCIALS
FIGURE 34 MICROPORT SCIENTIFC CORPORATION: SEGMENTAL REVENUE
FIGURE 35 MICROPORT SCIENTIFC CORPORATION: REGIONAL REVENUE
FIGURE 36 COOK MEDICAL: KEY FINANCIALS
FIGURE 37 COOK MEDICAL: SEGMENTAL REVENUE
FIGURE 38 COOK MEDICAL: REGIONAL REVENUE
FIGURE 39 VASCULAR CONCEPTS: KEY FINANCIALS
FIGURE 40 VASCULAR CONCEPTS: SEGMENTAL REVENUE
FIGURE 41 VASCULAR CONCEPTS: REGIONAL REVENUE
FIGURE 42 STENTYS S.A.: KEY FINANCIALS
FIGURE 43 STENTYS S.A.: SEGMENTAL REVENUE
FIGURE 44 STENTYS S.A.: REGIONAL REVENUE
FIGURE 45 C. R. BARD: KEY FINANCIALS
FIGURE 46 C. R. BARD: SEGMENTAL REVENUE
FIGURE 47 C. R. BARD: REGIONAL REVENUE
FIGURE 48 MERIL LIFE SCIENCES: KEY FINANCIALS
FIGURE 49 MERIL LIFE SCIENCES: SEGMENTAL REVENUE
FIGURE 50 MERIL LIFE SCIENCES: REGIONAL REVENUE
FIGURE 51 CORDIS CORPORATION: KEY FINANCIALS
FIGURE 52 CORDIS CORPORATION: SEGMENTAL REVENUE
FIGURE 53 CORDIS CORPORATION: REGIONAL REVENUE
FIGURE 54 W. L. GORE & ASSOCIATES: KEY FINANCIALS
FIGURE 55 W. L. GORE & ASSOCIATES: SEGMENTAL REVENUE
FIGURE 56 W. L. GORE & ASSOCIATES: REGIONAL REVENUE
